Not all patients with CLL involve therapy. Inspite of all recent improvements, the iwCLL nonetheless suggests watchful observation for people with asymptomatic disease.86 This recommendation is based on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Re